Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vectus Biosystems Limited ( (AU:VBS) ) has issued an update.
Vectus Biosystems Limited has announced the quotation of 75,000 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move follows the exercise of options or conversion of other convertible securities, potentially enhancing the company’s capital structure and market presence.
The most recent analyst rating on (AU:VBS) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Vectus Biosystems Limited stock, see the AU:VBS Stock Forecast page.
More about Vectus Biosystems Limited
Vectus Biosystems Limited operates in the biotechnology industry, focusing on the development of therapeutic products. The company is primarily engaged in creating treatments for fibrosis and high blood pressure, targeting significant health markets.
Average Trading Volume: 85,098
Technical Sentiment Signal: Hold
Current Market Cap: A$9.33M
Find detailed analytics on VBS stock on TipRanks’ Stock Analysis page.